HEADER TRANSFERASE 16-SEP-21 7S7K TITLE CRYSTAL STRUCTURE OF THE EPHB2 EXTRACELLULAR DOMAIN COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-B RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: NEURAL KINASE,NUK RECEPTOR TYROSINE KINASE,TYROSINE-PROTEIN COMPND 5 KINASE RECEPTOR EPH-3,TYROSINE-PROTEIN KINASE RECEPTOR SEK-3; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: EPHB2, EPTH3, NUK, SEK3; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_COMMON: CABBAGE LOOPER; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS EPHB2, ECD, AUTOINHIBITORY, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.XU,K.XU,D.B.NIKOLOV REVDAT 2 18-OCT-23 7S7K 1 REMARK REVDAT 1 27-OCT-21 7S7K 0 JRNL AUTH Y.XU,D.ROBEV,N.SAHA,B.WANG,M.B.DALVA,K.XU,J.P.HIMANEN, JRNL AUTH 2 D.B.NIKOLOV JRNL TITL THE EPHB2 RECEPTOR USES HOMOTYPIC, HEAD-TO-TAIL INTERACTIONS JRNL TITL 2 WITHIN ITS ECTODOMAIN AS AN AUTOINHIBITORY CONTROL JRNL TITL 3 MECHANISM. JRNL REF INT J MOL SCI V. 22 2021 JRNL REFN ESSN 1422-0067 JRNL PMID 34638814 JRNL DOI 10.3390/IJMS221910473 REMARK 2 REMARK 2 RESOLUTION. 3.15 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.19.2_4158 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.15 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.40 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.2 REMARK 3 NUMBER OF REFLECTIONS : 22492 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.215 REMARK 3 R VALUE (WORKING SET) : 0.214 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.120 REMARK 3 FREE R VALUE TEST SET COUNT : 1151 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.4000 - 6.2900 0.93 2719 133 0.1973 0.2452 REMARK 3 2 6.2800 - 4.9900 0.97 2670 159 0.1949 0.2157 REMARK 3 3 4.9900 - 4.3600 0.97 2633 147 0.1769 0.2152 REMARK 3 4 4.3600 - 3.9600 0.98 2658 141 0.2074 0.2241 REMARK 3 5 3.9600 - 3.6800 0.99 2678 145 0.2414 0.2647 REMARK 3 6 3.6800 - 3.4600 0.99 2695 140 0.2894 0.3232 REMARK 3 7 3.4600 - 3.2900 0.98 2624 140 0.2964 0.3608 REMARK 3 8 3.2900 - 3.1500 0.98 2664 146 0.3461 0.3755 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.490 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.300 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 116.9 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 115.9 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7S7K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-SEP-21. REMARK 100 THE DEPOSITION ID IS D_1000259768. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-JUL-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9795 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.20 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22540 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.145 REMARK 200 RESOLUTION RANGE LOW (A) : 48.400 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.0 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.04100 REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.15 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.79200 REMARK 200 R SYM FOR SHELL (I) : 0.79200 REMARK 200 FOR SHELL : 1.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 3FL7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 77.75 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 5.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.1 M NA SUCCINATE, 0.1M NA ACETATE PH REMARK 280 4.8, 5% (V/V) MPD, AND 3% 1, 6-HEXANEDIOL, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 36.92150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.43850 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.57100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 78.43850 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.92150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.57100 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 543 CG CD1 CD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 62 46.05 -141.92 REMARK 500 ASN A 133 66.58 -115.12 REMARK 500 GLU A 145 -3.18 63.99 REMARK 500 ALA A 228 -114.83 41.31 REMARK 500 GLU A 337 -131.30 62.61 REMARK 500 ASP A 355 36.68 -98.43 REMARK 500 PRO A 391 46.55 -80.96 REMARK 500 SER A 396 -154.69 -90.76 REMARK 500 ASP A 397 129.19 -33.91 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 133 PRO A 134 107.71 REMARK 500 REMARK 500 REMARK: NULL DBREF 7S7K A 19 543 UNP P54763 EPHB2_MOUSE 19 543 SEQRES 1 A 525 VAL GLU GLU THR LEU MET ASP SER THR THR ALA THR ALA SEQRES 2 A 525 GLU LEU GLY TRP MET VAL HIS PRO PRO SER GLY TRP GLU SEQRES 3 A 525 GLU VAL SER GLY TYR ASP GLU ASN MET ASN THR ILE ARG SEQRES 4 A 525 THR TYR GLN VAL CYS ASN VAL PHE GLU SER SER GLN ASN SEQRES 5 A 525 ASN TRP LEU ARG THR LYS PHE ILE ARG ARG ARG GLY ALA SEQRES 6 A 525 HIS ARG ILE HIS VAL GLU MET LYS PHE SER VAL ARG ASP SEQRES 7 A 525 CYS SER SER ILE PRO SER VAL PRO GLY SER CYS LYS GLU SEQRES 8 A 525 THR PHE ASN LEU TYR TYR TYR GLU ALA ASP PHE ASP LEU SEQRES 9 A 525 ALA THR LYS THR PHE PRO ASN TRP MET GLU ASN PRO TRP SEQRES 10 A 525 VAL LYS VAL ASP THR ILE ALA ALA ASP GLU SER PHE SER SEQRES 11 A 525 GLN VAL ASP LEU GLY GLY ARG VAL MET LYS ILE ASN THR SEQRES 12 A 525 GLU VAL ARG SER PHE GLY PRO VAL SER ARG ASN GLY PHE SEQRES 13 A 525 TYR LEU ALA PHE GLN ASP TYR GLY GLY CYS MET SER LEU SEQRES 14 A 525 ILE ALA VAL ARG VAL PHE TYR ARG LYS CYS PRO ARG ILE SEQRES 15 A 525 ILE GLN ASN GLY ALA ILE PHE GLN GLU THR LEU SER GLY SEQRES 16 A 525 ALA GLU SER THR SER LEU VAL ALA ALA ARG GLY SER CYS SEQRES 17 A 525 ILE ALA ASN ALA GLU GLU VAL ASP VAL PRO ILE LYS LEU SEQRES 18 A 525 TYR CYS ASN GLY ASP GLY GLU TRP LEU VAL PRO ILE GLY SEQRES 19 A 525 ARG CYS MET CYS LYS ALA GLY PHE GLU ALA VAL GLU ASN SEQRES 20 A 525 GLY THR VAL CYS ARG GLY CYS PRO SER GLY THR PHE LYS SEQRES 21 A 525 ALA ASN GLN GLY ASP GLU ALA CYS THR HIS CYS PRO ILE SEQRES 22 A 525 ASN SER ARG THR THR SER GLU GLY ALA THR ASN CYS VAL SEQRES 23 A 525 CYS ARG ASN GLY TYR TYR ARG ALA ASP LEU ASP PRO LEU SEQRES 24 A 525 ASP MET PRO CYS THR THR ILE PRO SER ALA PRO GLN ALA SEQRES 25 A 525 VAL ILE SER SER VAL ASN GLU THR SER LEU MET LEU GLU SEQRES 26 A 525 TRP THR PRO PRO ARG ASP SER GLY GLY ARG GLU ASP LEU SEQRES 27 A 525 VAL TYR ASN ILE ILE CYS LYS SER CYS GLY SER GLY ARG SEQRES 28 A 525 GLY ALA CYS THR ARG CYS GLY ASP ASN VAL GLN TYR ALA SEQRES 29 A 525 PRO ARG GLN LEU GLY LEU THR GLU PRO ARG ILE TYR ILE SEQRES 30 A 525 SER ASP LEU LEU ALA HIS THR GLN TYR THR PHE GLU ILE SEQRES 31 A 525 GLN ALA VAL ASN GLY VAL THR ASP GLN SER PRO PHE SER SEQRES 32 A 525 PRO GLN PHE ALA SER VAL ASN ILE THR THR ASN GLN ALA SEQRES 33 A 525 ALA PRO SER ALA VAL SER ILE MET HIS GLN VAL SER ARG SEQRES 34 A 525 THR VAL ASP SER ILE THR LEU SER TRP SER GLN PRO ASP SEQRES 35 A 525 GLN PRO ASN GLY VAL ILE LEU ASP TYR GLU LEU GLN TYR SEQRES 36 A 525 TYR GLU LYS GLU LEU SER GLU TYR ASN ALA THR ALA ILE SEQRES 37 A 525 LYS SER PRO THR ASN THR VAL THR VAL GLN GLY LEU LYS SEQRES 38 A 525 ALA GLY ALA ILE TYR VAL PHE GLN VAL ARG ALA ARG THR SEQRES 39 A 525 VAL ALA GLY TYR GLY ARG TYR SER GLY LYS MET TYR PHE SEQRES 40 A 525 GLN THR MET THR GLU ALA GLU TYR GLN THR SER ILE LYS SEQRES 41 A 525 GLU LYS LEU PRO LEU HET NAG B 1 14 HET NAG B 2 14 HET NAG C 1 14 HET NAG C 2 14 HET BMA C 3 11 HET NAG A 601 14 HET NAG A 602 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM BMA BETA-D-MANNOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN BMA BETA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 2 NAG 6(C8 H15 N O6) FORMUL 3 BMA C6 H12 O6 HELIX 1 AA1 THR A 27 ALA A 29 5 3 HELIX 2 AA2 VAL A 414 SER A 418 5 5 HELIX 3 AA3 SER A 479 ALA A 483 5 5 HELIX 4 AA4 THR A 529 LEU A 541 1 13 SHEET 1 AA1 5 GLU A 20 ASP A 25 0 SHEET 2 AA1 5 CYS A 184 CYS A 197 -1 O VAL A 192 N MET A 24 SHEET 3 AA1 5 ILE A 86 VAL A 94 -1 N GLU A 89 O ARG A 191 SHEET 4 AA1 5 VAL A 156 PHE A 166 -1 O PHE A 166 N ILE A 86 SHEET 5 AA1 5 PHE A 147 ASP A 151 -1 N VAL A 150 O MET A 157 SHEET 1 AA2 4 GLU A 44 TYR A 49 0 SHEET 2 AA2 4 THR A 55 CYS A 62 -1 O ILE A 56 N GLY A 48 SHEET 3 AA2 4 CYS A 184 CYS A 197 -1 O MET A 185 N VAL A 61 SHEET 4 AA2 4 THR A 210 LEU A 211 -1 O THR A 210 N CYS A 197 SHEET 1 AA3 4 MET A 36 HIS A 38 0 SHEET 2 AA3 4 ASN A 71 ARG A 74 -1 O TRP A 72 N HIS A 38 SHEET 3 AA3 4 GLY A 173 ASP A 180 -1 O ASP A 180 N ASN A 71 SHEET 4 AA3 4 ILE A 78 ARG A 79 -1 N ILE A 78 O PHE A 174 SHEET 1 AA4 5 MET A 36 HIS A 38 0 SHEET 2 AA4 5 ASN A 71 ARG A 74 -1 O TRP A 72 N HIS A 38 SHEET 3 AA4 5 GLY A 173 ASP A 180 -1 O ASP A 180 N ASN A 71 SHEET 4 AA4 5 THR A 110 ALA A 118 -1 N ALA A 118 O GLY A 173 SHEET 5 AA4 5 VAL A 136 ALA A 142 -1 O VAL A 138 N LEU A 113 SHEET 1 AA5 3 ILE A 200 GLN A 202 0 SHEET 2 AA5 3 ALA A 205 PHE A 207 -1 O PHE A 207 N ILE A 200 SHEET 3 AA5 3 SER A 225 CYS A 226 -1 O SER A 225 N ILE A 206 SHEET 1 AA6 3 VAL A 220 ARG A 223 0 SHEET 2 AA6 3 ALA A 230 CYS A 241 -1 O LEU A 239 N ALA A 222 SHEET 3 AA6 3 ILE A 251 CYS A 256 -1 O ILE A 251 N LYS A 238 SHEET 1 AA7 2 PHE A 260 VAL A 263 0 SHEET 2 AA7 2 VAL A 268 GLY A 271 -1 O VAL A 268 N VAL A 263 SHEET 1 AA8 2 THR A 276 PHE A 277 0 SHEET 2 AA8 2 THR A 287 HIS A 288 -1 O THR A 287 N PHE A 277 SHEET 1 AA9 2 SER A 293 ARG A 294 0 SHEET 2 AA9 2 VAL A 304 CYS A 305 -1 O VAL A 304 N ARG A 294 SHEET 1 AB1 4 GLN A 329 ASN A 336 0 SHEET 2 AB1 4 SER A 339 THR A 345 -1 O GLU A 343 N ILE A 332 SHEET 3 AB1 4 ARG A 392 ILE A 395 -1 O ILE A 393 N LEU A 342 SHEET 4 AB1 4 TYR A 381 ALA A 382 -1 N ALA A 382 O TYR A 394 SHEET 1 AB2 3 VAL A 357 CYS A 365 0 SHEET 2 AB2 3 GLN A 403 VAL A 411 -1 O VAL A 411 N VAL A 357 SHEET 3 AB2 3 PHE A 424 THR A 430 -1 O ALA A 425 N ILE A 408 SHEET 1 AB3 3 MET A 442 ARG A 447 0 SHEET 2 AB3 3 ILE A 452 TRP A 456 -1 O THR A 453 N SER A 446 SHEET 3 AB3 3 THR A 492 VAL A 495 -1 O VAL A 493 N LEU A 454 SHEET 1 AB4 4 THR A 484 SER A 488 0 SHEET 2 AB4 4 ILE A 466 GLU A 475 -1 N LEU A 471 O ILE A 486 SHEET 3 AB4 4 ILE A 503 THR A 512 -1 O ARG A 509 N GLU A 470 SHEET 4 AB4 4 GLY A 515 TYR A 516 -1 O GLY A 515 N THR A 512 SHEET 1 AB5 4 THR A 484 SER A 488 0 SHEET 2 AB5 4 ILE A 466 GLU A 475 -1 N LEU A 471 O ILE A 486 SHEET 3 AB5 4 ILE A 503 THR A 512 -1 O ARG A 509 N GLU A 470 SHEET 4 AB5 4 MET A 523 GLN A 526 -1 O MET A 523 N PHE A 506 SSBOND 1 CYS A 62 CYS A 184 1555 1555 2.03 SSBOND 2 CYS A 97 CYS A 107 1555 1555 2.03 SSBOND 3 CYS A 197 CYS A 241 1555 1555 2.03 SSBOND 4 CYS A 226 CYS A 254 1555 1555 2.03 SSBOND 5 CYS A 256 CYS A 269 1555 1555 2.03 SSBOND 6 CYS A 272 CYS A 286 1555 1555 2.03 SSBOND 7 CYS A 289 CYS A 303 1555 1555 2.03 SSBOND 8 CYS A 305 CYS A 321 1555 1555 2.03 SSBOND 9 CYS A 362 CYS A 375 1555 1555 2.03 SSBOND 10 CYS A 365 CYS A 372 1555 1555 2.03 LINK ND2 ASN A 265 C1 NAG A 602 1555 1555 1.44 LINK ND2 ASN A 336 C1 NAG A 601 1555 1555 1.44 LINK ND2 ASN A 428 C1 NAG B 1 1555 1555 1.44 LINK ND2 ASN A 482 C1 NAG C 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.45 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG C 2 C1 BMA C 3 1555 1555 1.45 CISPEP 1 HIS A 38 PRO A 39 0 -2.04 CISPEP 2 PHE A 127 PRO A 128 0 -4.50 CISPEP 3 GLY A 167 PRO A 168 0 3.93 CISPEP 4 VAL A 235 PRO A 236 0 -0.99 CISPEP 5 ALA A 382 PRO A 383 0 2.86 CISPEP 6 LEU A 541 PRO A 542 0 -0.70 CRYST1 73.843 111.142 156.877 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013542 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008997 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006374 0.00000